Drug intelligence / Profile preview

KAM2904 + KAM3008

Development stage
Unknown
Lead developer
Kamedis
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

KAM2904 + KAM3008 is a combination of two topical botanical formulations developed by Kamedis Ltd. for the management of mild to moderate atopic dermatitis (eczema) in children. KAM2904 is a face cream and KAM3008 is a body lotion, both of which are formulated with botanical extracts derived from Traditional Chinese Medicine (TCM) intended to restore the skin barrier and provide anti-inflammatory effects. The combination has been evaluated in clinical trials (such as NCT03810105) to assess its efficacy in reducing disease severity, as measured by SCORAD and Eczema Area Severity Index (EASI) scores, compared to standard petrolatum-based moisturizers. These products are often classified as medical devices or cosmeceuticals depending on the regulatory jurisdiction.

Other names
KAM2904 + KAM3008

Beyond the preview

Go deeper on KAM2904 + KAM3008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KAM2904 + KAM3008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call